Skip to main content

Mª Jesús Cruz Carmona

Institutions of which they are part

Head of group
Pneumology
Vall Hebron Institut de Recerca

Mª Jesús Cruz Carmona

Institutions of which they are part

Head of group
Pneumology
Vall Hebron Institut de Recerca

Projects

Potencial terapeútico de las células madre mesenquimales modificadas para secretar la proteína anti-inflamatoria sST2 en un modelo murino de asma ocupacional

IP: Mª Jesús Cruz Carmona
Collaborators: César Laborda Soriano, Oriol Roca Gas, Susana Gómez Olles
Funding agency: Instituto de Salud Carlos III
Funding: 39325
Reference: PI10/00782
Duration: 01/01/2011 - 31/12/2013

Desarrollo de un modelo animal para el estudio del asma ocupacional ocasionada por la exposición a sales de persulfato

IP: Fco. Javier Muñoz Gall
Collaborators: Mª Jesús Cruz Carmona
Funding agency: Instituto de Salud Carlos III
Funding: 34848
Reference: PI080204
Duration: 01/01/2009 - 31/12/2011

Unitat de Recerca de Pneumologia

IP: Ferran Morell Brotad
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Ana Villar Gomez, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Patricia Lloberes Canadell, Javier de Gracia Roldán, Sonia Lopez Rodriguez, Montserrat Murillo Andres, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Jaume Ferrer Sancho, Maria Antonia Ramon Belmonte, Rosa Lloria Verges, Oriol Roca Gas, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Manuel López Meseguer, Susana Gómez Olles
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 54080
Reference: 2009 SGR 257
Duration: 01/01/2010 - 30/04/2014

Desarrollo de un modelo animal para el estudio del asma ocupacional ocasionada por la exposición a sales de persulfato

IP: Fco. Javier Muñoz Gall
Collaborators: Mª Jesús Cruz Carmona
Funding agency: SOCIETAT CATALANA DE PNEUMOLOGIA
Funding: 18000
Reference: SOCAP/01/2007
Duration: 23/03/2007 - 22/03/2010

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Immaculada Creus Gonzalez

Immaculada Creus Gonzalez

Research technician
Read more
Marta Miarons Font

Marta Miarons Font

Head of group
Basic, Translational and Clinical Pharmacy Research
Read more
Alvaro Garcia Tornel Garcia Camba

Alvaro Garcia Tornel Garcia Camba

Senior researcher
Stroke research
Read more
Ferran Polo Torres

Ferran Polo Torres

Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.